Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Gable

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Cell Reports|January 29, 2024
Collaborative regulation of yeast SPT-Orm2 complex by phosphorylation and ceramideTian Xie, Feitong Dong, Gongshe Han, et al.
Cell Reports|November 19, 2013
TORC1 inhibits GSK3-mediated Elo2 phosphorylation to regulate very long chain fatty acid synthesis and autophagyChristine Zimmermann, Aline Santos, Kenneth Gable, et al.
Science Advances|March 29, 2023
Mechanism of sphingolipid homeostasis revealed by structural analysis of <i>Arabidopsis</i> SPT-ORM1 complexPeng Liu, Tian Xie, Xinyue Wu, et al.
Scientific Reports|January 14, 2016
A Signaling Lipid Associated with Alzheimer's Disease Promotes Mitochondrial DysfunctionMichael A Kennedy, Tia C Moffat, Kenneth Gable, et al.
The Plant Cell|March 23, 2011
Sphingolipids in the root play an important role in regulating the leaf ionome in Arabidopsis thalianaDai-Yin Chao, Kenneth Gable, Ming Chen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 2, 2023
Recurrent <i>de-novo gain-of-function</i> mutation in <i>SPTLC2</i> confirms dysregulated sphingolipid production to cause juvenile amyotrophic lateral sclerosisMaike F Dohrn, Danique Beijer, Museer A Lone, et al.
Brain : a Journal of Neurology|January 31, 2023
SPTSSA variants alter sphingolipid synthesis and cause a complex hereditary spastic paraplegiaSiddharth Srivastava, Hagar Mor Shaked, Kenneth Gable, et al.
Neuropathology and Applied Neurobiology|July 29, 2022
The SPTLC1 p.S331 mutation bridges sensory neuropathy and motor neuron disease and has implications for treatmentChiara Fiorillo, Giovanna Capodivento, Alessandro Geroldi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 2, 2023
Recurrent de novo <i>SPTLC2</i> variant causes childhood-onset amyotrophic lateral sclerosis (ALS) by excess sphingolipid synthesisSafoora B Syeda, Museer A Lone, Payam Mohassel, et al.
Nature Medicine|June 1, 2021
Childhood amyotrophic lateral sclerosis caused by excess sphingolipid synthesisPayam Mohassel, Sandra Donkervoort, Museer A Lone, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Cell Reports|January 29, 2024
Collaborative regulation of yeast SPT-Orm2 complex by phosphorylation and ceramideTian Xie, Feitong Dong, Gongshe Han, et al.
Cell Reports|November 19, 2013
TORC1 inhibits GSK3-mediated Elo2 phosphorylation to regulate very long chain fatty acid synthesis and autophagyChristine Zimmermann, Aline Santos, Kenneth Gable, et al.
Science Advances|March 29, 2023
Mechanism of sphingolipid homeostasis revealed by structural analysis of <i>Arabidopsis</i> SPT-ORM1 complexPeng Liu, Tian Xie, Xinyue Wu, et al.
Scientific Reports|January 14, 2016
A Signaling Lipid Associated with Alzheimer's Disease Promotes Mitochondrial DysfunctionMichael A Kennedy, Tia C Moffat, Kenneth Gable, et al.
The Plant Cell|March 23, 2011
Sphingolipids in the root play an important role in regulating the leaf ionome in Arabidopsis thalianaDai-Yin Chao, Kenneth Gable, Ming Chen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 2, 2023
Recurrent <i>de-novo gain-of-function</i> mutation in <i>SPTLC2</i> confirms dysregulated sphingolipid production to cause juvenile amyotrophic lateral sclerosisMaike F Dohrn, Danique Beijer, Museer A Lone, et al.
Brain : a Journal of Neurology|January 31, 2023
SPTSSA variants alter sphingolipid synthesis and cause a complex hereditary spastic paraplegiaSiddharth Srivastava, Hagar Mor Shaked, Kenneth Gable, et al.
Neuropathology and Applied Neurobiology|July 29, 2022
The SPTLC1 p.S331 mutation bridges sensory neuropathy and motor neuron disease and has implications for treatmentChiara Fiorillo, Giovanna Capodivento, Alessandro Geroldi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 2, 2023
Recurrent de novo <i>SPTLC2</i> variant causes childhood-onset amyotrophic lateral sclerosis (ALS) by excess sphingolipid synthesisSafoora B Syeda, Museer A Lone, Payam Mohassel, et al.
Nature Medicine|June 1, 2021
Childhood amyotrophic lateral sclerosis caused by excess sphingolipid synthesisPayam Mohassel, Sandra Donkervoort, Museer A Lone, et al.
Pageof 3